Want to see CRMD full AI Analyst Report?
Cormedix (CRMD) Income Statement
Cormedix Income Statement
Last quarter (Q2 2026), Cormedix's total revenue was $101.93M, an increase of 156.52% from the same quarter last year. In Q2, Cormedix's net income was $25.99M. See Cormedix’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 311.71M | $ 43.47M | $ 0.00 | $ 65.41K | $ 190.94K | |
| $ 275.75M | $ 40.28M | $ -205.56K | $ 61.67K | $ 42.00K | |
| $ 125.61M | $ 62.64M | $ 48.75M | $ 30.69M | $ 29.48M | |
| Depreciation and Amortization | $ 14.55M | $ 310.00K | $ 70.75K | $ 84.62K | $ 61.89K |
| $ 167.35M | $ -18.98M | $ -46.23M | $ -30.18M | $ -29.38M | |
| $ 150.14M | $ -22.36M | $ -48.96M | $ -30.62M | $ -29.44M | |
| $ -125.00K | $ 3.03M | $ 2.62M | $ 336.65K | $ -22.83K | |
| $ 150.02M | $ -19.32M | $ -46.34M | $ -30.29M | $ -29.46M | |
| $ 163.06M | $ -17.93M | $ -46.34M | $ -29.70M | $ -28.21M | |
| Per Share Metrics | |||||
| Basic EPS | $ 2.25 | $ -0.30 | $ -0.91 | $ -0.74 | $ -0.75 |
| Diluted EPS | $ 2.04 | $ -0.30 | $ -0.91 | $ -0.74 | $ -0.75 |
| Weighted Average Shares Outstanding | 72.03M | 58.87M | 50.90M | 40.14M | 37.61M |
| Weighted Average Shares Outstanding (Diluted) | 80.31M | 58.87M | 50.90M | 40.27M | 37.67M |
Currency in USD